12 news items
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
JAZZ
20 Jun 24
, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
ATNM
BMRN
EXEL
17 Jun 24
results or events. Past performance does not guarantee future results.InvestorBrandMedia.com does not commit to updating forward-looking statements
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
not guarantee future results.InvestorBrandMedia.com does not commit to updating forward-looking statements based on new information or future events. Readers
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
JAZZ
1 Jun 24
countries committed to serving patients worldwide. Please visit
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
JAZZ
30 May 24
abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders
vv2y bninpb4sd
JAZZ
29 May 24
facilities and employees in multiple countries committed to serving patients worldwide. Please visit
4tq08q122 0w
JAZZ
29 May 24
countries committed to serving patients worldwide. Please visit
xdb zqyy3k8p3eqii9t
JAZZ
22 May 24
in the United States. This partnership reinforces Jazz's commitment to supporting
t369zw12j4fyd43oa6hoyr7lkknm3h3
JAZZ
1 May 24
in multiple countries committed to serving patients worldwide. Please visit
sk5no7yfl
JAZZ
24 Apr 24
at this year's meeting demonstrate our commitment to advancing our portfolio of innovative oncology products and investigational therapies at all stages
o33owj9 dkrzf9x1
JAZZ
17 Apr 24
facilities and employees in multiple countries committed to serving patients worldwide. Please visit
0k1gfpf1kz9z2b246fsm5agbyw09wu4xntw1qcup1qipr581pq9ht
JAZZ
10 Apr 24
presentations at the 2024 AAN Annual Meeting reflect our leadership in sleep and rare epilepsies, as well as our commitment to developing therapies
- Prev
- 1
- Next